Abstract:Objective To investigate the synergetic role in inducing apoptosis of osteosarcoma cell(MG-63)when tumor necrosis factor-related apoptosis inducing ligand(TRAIL)combined with interferon(IFN)-γ.to explore the potential mechanism of synergistic antitumor activity,and to observe the toxicity of TRAIL combined with IFN-γin fibroblast.Methods The mor- pholngy was observed with inverted phase contrast microscope and electronic microscope after MC-63 was treated by TRATL, IFN-γ,and TRAIL combined with IFN-γRespectively inhibition rate and apoptosis rate was assessed by methyl thiazolyl tet- razolizm(MTT)assay and flow cytometer(FCM).After MG-63 was intervened by IFN-γ.the expression of TRAIL receptors was detected by Reverse Transcription-Polymerase Chain Reaction(RT-PCR).The toxicity of TRAIL combined with IFN-γin fihro- blast was evaluated by MTT assay.Results The growth activity of MG-63 was weakened after it was intervened by TRAIL com- bined with IFN-γ.When it was treated by IFN-γfor 24 hours,then combined with TRAIL,it showed the lowest activity.The Electronic microscope could reveal the apoptosis characteristic changes.The inhibition rate of MG-63 increased obviously by combi- ning TRAIL and IFN-γ,comparing with administration of TRAIL alone,and the difference was statistically significant(P0.01).The apoptosis rate of MG-63 increased obviously by combining TRAIL and IFN-γ,and the difference was significant(P0.01).The expression of death receptor(DR)4 was increased significantly(P0.01)when MG-63 had been treated with IFN-γfor 24 hours.The toxicity of TRAIL combined with IFN-γin fibroblast was not increased(P0.05).Conclusions IFN-γhad synergetic role in the apoptosis effect induced by TRAIL in MG-63.Up-regulating DR4 might he one of the reasons for synergetic antitumor activity.The risk of toxicity in fibroblast was not raised when TRAIL combined with IFN-γ.

Proteasome inhibitor MG-132 reverses acquired resistance to TRAIL in human colon cancer cells

Proteasome Inhibitor MG132 Enhances TRAIL-induced Apoptosis and Inhibits Invasion of Human Osteosarcoma OS732 Cells

Overcoming Acquired TRAIL Resistance in Human Colon Cancer by Proteasome Inhibitor Bortezomib

Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanisms.

Effects of Different Chemotherapeutic Agents on Reversing the Acquired Resistance to TRAIL Gene in DLD1 Colon Cancer Cells

Molecular Mechanisms of Resistance to TRAIL-induced Apoptosis in Tumor

Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation.

Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer

17-hydroxy wortmannin restores TRAIL's response by ameliorating increased beclin 1 level and autophagy function in TRAIL-resistant colon cancer cells.

Combination of PHA-767491 with TRAIL Inhibits Proliferation of Hepatocellular Carcinoma Bel-7404 Cells

Supplementary Tables S1-S8 from 17-Hydroxy Wortmannin Restores TRAIL's Response by Ameliorating Increased Beclin 1 Level and Autophagy Function in TRAIL-Resistant Colon Cancer Cells

Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29.

Accelerated Degradation of Caspase-8 Protein Correlates with TRAIL Resistance in a DLD1 Human Colon Cancer Cell Line.

Resistance to TRAIL is mediated by DARPP-32 in gastric cancer

Induction of Apoptosis and Accumulation of P27kip1 Protein by Proteasome Inhibitor MG132 in Human Osteosarcoma MG-63 Cells

Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part Through the Inhibition of the Phosphatidylinositol 3-Kinase/akt Pathway

Activity of TRAIL Gene Modification Combined with DOX on Human Colon Cancer Cell Line RKO

Experimental Study on Apoptosis of Osteosarcoma Cell Induced by TRAIL Combined with IFN-γ

[Action of Apoptosis-Induced Ligand Gene in Relation to Tumor Necrosis Factor on Human Colon Cancer Cell Line HT29].

Tumor Suppression Activity of Ginsenoside Rg3 Combined with TRAIL Gene on Human Colon Cancer Cell Line HCE8693

Experimental study of the killing effect of proteasome inhibitor MG132 on gallbladder cancer cells